Isoalantolactone suppresses gallbladder cancer progression via inhibiting the ERK signalling pathway

Isoalantolactone suppresses gallbladder cancer progression via inhibiting the ERK signalling pathway

AbstractContext Gallbladder cancer (GBC) is the most common malignant tumour of the biliary tract. Isoalantolactone (IAL), an active sesquiterpene lactone compound isolated from the roots of Inula helenium L. (Asteraceae), has antitumour effects.Objective This study investigates the effects of IAL o...

Full description

Bibliographic Details
Main Authors: Xingyu Lv, Yuqi Lin, Xi Zhu, Xiujun Cai
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Pharmaceutical Biology
Subjects:
IAL
traditional Chinese medicine
antitumour drug
Ro 67-7476
MAPK
Online Access:https://www.tandfonline.com/doi/10.1080/13880209.2023.2191645

Similar Items

Similar Items